Patient guide

B29 OG Cannabis Strain Information & Review

The B29 OG cannabis strain is a hybrid with a genetic background of Green Crack and Holy Grail Kush, offering a unique combination of characteristics that may appeal to some users. While strain reviews can provide...

13 June 2026 5 min read min read

The B29 OG cannabis strain is a hybrid with a genetic background of Green Crack and Holy Grail Kush, offering a unique combination of characteristics that may appeal to some users. While strain reviews can provide insights into appearance, aroma, taste, and effects, it is important to approach such information with caution. This guide aims to present the available information on B29 OG in a factual and balanced manner, helping patients and carers understand what to expect and when to seek professional advice.

Key takeaways

  • B29 OG is a hybrid cannabis strain with a genetic mix of Green Crack and Holy Grail Kush, potentially offering a balance of uplifting and relaxing effects.
  • The strain is described as having a sweet, pungent aroma and a complex, weedy taste, with a smooth but voluminous smoke.
  • It is reported to produce a hybrid high leaning towards the energizing effects of Green Crack, making it suitable for daytime use.
  • The effects are noted to be strong but not immediately potent, with a delayed onset of action.

Evidence base

The information provided about B29 OG is primarily based on a strain review from a commercial source, which describes the appearance, aroma, taste, and effects of the strain. The review highlights the visual quality of the buds, the rich and complex scent, and the smooth yet voluminous smoke. It also notes the hybrid effects, suggesting a balance between uplifting and relaxing properties. However, this information is anecdotal and based on a single source, which may not be representative of the broader experience of users. There is limited scientific evidence on the specific effects or safety of B29 OG, and the claims made in the review should be considered as part of the broader context of cannabis strain variability. The review does not provide data on potency, dosage, or long-term effects, which are important factors for patients and carers to consider.

The review also mentions the strain's potential for daily use, but this is a subjective assessment and does not account for individual differences in response to cannabis. The lack of standardized testing or clinical trials means that the reported effects may vary significantly between individuals. Additionally, the review does not address the legal status of cannabis in the UK, which is a critical consideration for users. The information provided is therefore best viewed as a general overview rather than a definitive guide to the effects or safety of B29 OG.

What patients should know

When considering the use of B29 OG or any cannabis strain, it is important to understand that the effects can vary widely between individuals. Factors such as dosage, method of use, and individual physiology can all influence the experience. The review suggests that B29 OG may offer a balance of uplifting and relaxing effects, but this is based on a single source and should not be taken as a guarantee. Patients should be aware that the reported effects may not be consistent with their own experience.

The method of use also plays a significant role in the effects of cannabis. The review describes the use of a bong, which can affect the potency and delivery of the active compounds. Patients should consider the method of use and how it may influence their experience. It is also important to note that the review does not provide information on the potency of B29 OG, which can vary between batches and sources. Patients should be cautious about relying on anecdotal reports and instead seek information from reliable sources.

Finally, patients should be aware of the legal status of cannabis in the UK. While cannabis for medicinal use is available under specific conditions, recreational use remains illegal. Patients should consult with a clinician to understand the legal implications and to ensure that their use of cannabis is both safe and appropriate for their individual circumstances.

When to speak to a clinician

Patients should consider speaking to a clinician if they are experiencing any adverse effects from the use of B29 OG or any cannabis strain. This includes symptoms such as anxiety, paranoia, or sleep disturbances. It is also important to consult a clinician if the effects of the strain are not consistent with the expected outcomes or if there are concerns about the safety or legality of its use. Patients should also seek professional advice if they are considering using cannabis for a medical condition, as the potential benefits and risks should be carefully evaluated.

Red flags or review points to consider when speaking to a clinician include:

  • Any changes in mood, behavior, or mental health
  • Physical symptoms such as dizziness, nausea, or respiratory issues
  • Concerns about the legal status or safety of cannabis use
  • Questions about the appropriate dosage or method of use

Questions to ask a clinician

  • What are the potential benefits and risks of using B29 OG or similar strains for my specific condition?
  • How can I determine the appropriate dosage and method of use for cannabis?
  • What are the legal implications of using cannabis for medicinal or recreational purposes?

Source trail

  • B29 OG Strain Review from ISMOKE on Vimeo
  • Commercial strain review providing anecdotal information on appearance, aroma, taste, and effects
  • General guidance on cannabis use and legal status in the UK